Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2012
10/16/2012CA2588063C 2-methylene-19,21-dinor-1.alpha.-hydroxy-bishomopregnacalciferol
10/16/2012CA2577550C Use of the combination comprising temozolomide and tnf-alpha for treating glioblastoma
10/16/2012CA2563895C Disalt inhibitors of il-12 production
10/16/2012CA2563058C Supportive treatment of liver disease
10/16/2012CA2562313C Systems and methods for administering a medical regimen
10/16/2012CA2561635C New crystalline form of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
10/16/2012CA2558545C Indol-1-yl-acetic acid derivatives
10/16/2012CA2557324C Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
10/16/2012CA2554426C Agents for treating migraine
10/16/2012CA2549801C Use of treprostinil to improve kidney functions
10/16/2012CA2548915C Generally linear effervescent oral fentanyl dosage form and methods of administering
10/16/2012CA2544697C Method of preparing carboxylic acid functionalized polymers
10/16/2012CA2544155C Drug and method for proliferating natural killer cells
10/16/2012CA2536108C Compositions and methods for detecting and treating hereditary spastic paraplegia
10/16/2012CA2530136C In-situ gelling drug delivery system
10/16/2012CA2527396C Method for the treatment or prevention of lower urinary tract symptoms
10/16/2012CA2526884C P2x7 receptor antagonists and their use
10/16/2012CA2526866C Substituted 3-sulfur indoles for treating a disease mediated by crth2
10/16/2012CA2525841C Cyclohexyl sulphones as gamma-secretase inhibitors
10/16/2012CA2523854C Crystals of quinolinecarboxylic acid derivative solvate
10/16/2012CA2521268C Topical anthelmintic veterinary formulations
10/16/2012CA2519253C Carnitine retention
10/16/2012CA2505040C Composition for iontophoretic delivery of rotigotine
10/16/2012CA2504933C Methods and compositions for treating cancer using proteasome inhibitors
10/16/2012CA2496477C Synthesis of epothilones, intermediates thereto, analogues and uses thereof
10/16/2012CA2485794C Triptolide derivatives for modulation of apoptosis and immunosuppression
10/16/2012CA2485681C Ccr9 inhibitors and methods of use thereof
10/16/2012CA2478700C Analysis of sulfated polysaccharides
10/16/2012CA2471906C A liquid pharmaceutical formulation comprising nicotine for the administration to the oral cavity
10/16/2012CA2466773C Inhibitor oligonucleotides and their use for specific repression of a gene
10/16/2012CA2456049C Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction
10/16/2012CA2446781C Coated granules based on angiotensin-converting enzyme inhibitor
10/16/2012CA2443069C Synthesis and use of glycodendrimer reagents
10/16/2012CA2439763C Pharmaceutical compositions based on anticholinergics and pde-iv inhibitors
10/16/2012CA2422865C Aminolevulinic acid photodynamic therapy for treating sebaceous gland disorders
10/16/2012CA2419404C Compositions and methods for treating sexual dysfunction
10/16/2012CA2393904C Hepoxilin analogs
10/16/2012CA2364300C A skin care composition that mediates cell to cell communication
10/16/2012CA2250970C Cyclosporin emulsions
10/11/2012WO2012139134A2 Methods of modulating oncogenic fusion proteins
10/11/2012WO2012139119A1 Small molecule therapeutic compounds targeting thioesterase deficiency disorders and methods of using the same
10/11/2012WO2012139093A2 Selective androgen receptor modulators for treating diabetes
10/11/2012WO2012139074A2 Migrastatins and uses thereof
10/11/2012WO2012139045A1 Methods and compositions for normalization of tumor vasculature by inhibition of loxl2
10/11/2012WO2012139043A2 Selective neuronal nitric oxide synthase inhibitors
10/11/2012WO2012139033A1 Methods and compositions for treating raynaud's disease
10/11/2012WO2012139028A2 Anti-viral combination therapy
10/11/2012WO2012139027A1 Methods and compositions for treating neurodegenerative diseases
10/11/2012WO2012139021A2 TARGETING HK alpha FOR CONTROLLING BLOOD PRESSURE AND REGULATING ELECTROLYTE BALANCE
10/11/2012WO2012139019A2 New indolinone protein kinase inhibitors
10/11/2012WO2012139015A1 Polymers and methods for the treatment of pain
10/11/2012WO2012139010A1 Grp94 inhibitors
10/11/2012WO2012139001A2 Kinase protein binding inhibitors
10/11/2012WO2012138963A1 Inositol hexakisphosphate analogs and uses thereof
10/11/2012WO2012138945A1 Methods of treating schizophrenia with pyrazole derivative inhibitors of tgf - beta
10/11/2012WO2012138938A1 Aminopyrazine compounds useful as inhibitors of tra kinase
10/11/2012WO2012138907A2 Solid forms of curcumin
10/11/2012WO2012138899A1 Reducing dental caries
10/11/2012WO2012138888A1 Process for the synthesis of quaternary amine compounds
10/11/2012WO2012138877A1 N1- and n2-carbamoyl-1,2,3-triazole serine hydrolase inhibitors and methods
10/11/2012WO2012138857A2 Methods and materials for reducing supression of immune function
10/11/2012WO2012138846A2 Method and compositions comprising small rna agonist and antagonists to modulate inflammation
10/11/2012WO2012138845A1 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
10/11/2012WO2012138809A1 Heterocyclic compounds as kinase inhibitors
10/11/2012WO2012138797A1 3- or 5 - bi phenyl - 4 - ylisoxazole - based compounds useful for the treatment of fibrosis, pain, cancer and respiratory, allergic, nervous system or cardiovascular disorders
10/11/2012WO2012138776A1 Benzodioxepine and benzodioxine compounds that interact with glucokinase regulatory protein for the treatment of diabetes
10/11/2012WO2012138765A1 Methods of treating central nervous system tumors
10/11/2012WO2012138734A1 C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
10/11/2012WO2012138715A2 Small molecule inhibitors of xbp1 splicing
10/11/2012WO2012138713A2 Multifunctional radical quenchers for the treatment of mitochondrial dysfunction
10/11/2012WO2012138706A1 Epoxyeicosatrienoic acid analogs and methods of making and using the same
10/11/2012WO2012138698A1 Synthesis of beta-mannuronic acid oligosaccharides
10/11/2012WO2012138691A2 Diagnosis and treatment of taxane-resistant cancers
10/11/2012WO2012138678A1 Gamma secretase inhibitors
10/11/2012WO2012138669A1 Solid state forms of hiv inhibitor
10/11/2012WO2012138653A2 Treatment regimens
10/11/2012WO2012138648A1 Compositions and methods for modulating lpa receptors
10/11/2012WO2012138575A1 Compositions and methods for increasing muscle function and mass
10/11/2012WO2012138467A1 Photostabilization of resveratrol with alkoxycrylene compounds
10/11/2012WO2012138297A1 Acetyltanshinone iia (ata) as anticancer agent
10/11/2012WO2012138289A1 Diagnosis and treatment of friedreich's ataxia
10/11/2012WO2012138246A1 Pharmaceutical composition for treating hyperproliferative diseases
10/11/2012WO2012138226A1 Beta-guanidinopropionic acid for the treatment of hypertension
10/11/2012WO2012138214A1 Beta-guanidinopropionic acid for the treatment of hypertension
10/11/2012WO2012138213A1 Reduction of vascular dysfunction with specific saccharides
10/11/2012WO2012138184A2 Drug-eluting stent comprising chitosan coating layer, and preparation method thereof
10/11/2012WO2012138147A2 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid crystalline form and the producing method thereof
10/11/2012WO2012138043A2 Therapeutic composition containing endothelin as an active component
10/11/2012WO2012138013A1 Paclitaxel-loaded polymeric nanoparticle and preparation thereof
10/11/2012WO2012138003A1 Uses of a desulfated heparin-bile acid derivative for the prevention and treatment of inflammatory diseases
10/11/2012WO2012137987A1 Method for treating asthenopia
10/11/2012WO2012137971A1 Combinations comprising brexpiprazole or a salt thereof and a second drug for use in the treatment of a cns disorder
10/11/2012WO2012137967A1 Calcium phosphate microcapsule
10/11/2012WO2012137932A1 Composition for external application
10/11/2012WO2012137885A1 Agent for inhibiting or preventing renal interstitial fibrosis
10/11/2012WO2012137870A1 Novel imidazo-oxazine compound or salt thereof
10/11/2012WO2012137667A1 Method for producing fine powder of loxoprofen sodium dihydrate for pharmaceutical preparations
10/11/2012WO2012137610A1 Pharmaceutical preparation
10/11/2012WO2012137225A1 Substituted methylformyl reagents and method of using same to modify physicochemical and/or pharmacokinetic properties of compounds
10/11/2012WO2012137224A1 Coumarin compounds for the treatment of mycobacterial infections
1 ... 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 ... 7860